1Warring S,Baisley K,Boyle M,et al. Effects of rabeprazole, 20 mg, or esomeprazole, 20mg, on 24-h intragastric pH and serum gastrin in healthy subjects[J]. Aliment Pharmacol Ther, 2002,16(7) :1301-1307.
2Wilder-Smith CH, Rochssk, Nilsson Pieschl C, et al.Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30mg and rabeprazole 20mg in healthy volunteers[J]. Digestion,2003,68(4) : 184-188.
3Andersson T,Rohss K,Bredberq E,et al. Pharmaeokinetics and pharmacodynamies of esomeprazole,the S-isomer of omeprazole [J]. Aliment Pharmacol Ther,2001,15(10):1563-1569.
7Nagashima K, Wakayama M, Yaguchi M, et al.A patient with Sjogren syndrome with central pontine myelinolysis and hypokalemic myopathy [J]. Rinsho Shinkeigaku, 1996,36:1240- 1244
8Yoon KH, Fong KY, Koh DR, et al. Central pontine myelinolysis - a rare manifestation of CNS Sjogren's syndrome[J]. Lupus,2000, 9:471-473
9Vitali C, Bombardieri S, Jonsson R, et al. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group [J]. Ann Rheum Dis, 2002,61:554-558
